Clinical Trial Update: European Trial of Dronedarone in Moderate to Severe Congestive Heart Failure [Phase 3]

View source ↗

Summary

A European Phase 3 trial of dronedarone for moderate to severe congestive heart failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Multaq (dronedarone)

Snippet

Sponsor: Sanofi | Conditions: Congestive Heart Failure | Phase 3 | Status: TERMINATED